Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BrainAurora Medical Technology Limited ( (HK:6681) ) just unveiled an update.
BrainAurora Medical Technology Limited has announced a significant change in its board composition with the resignation of Mr. Li Yuezhong as an independent non-executive director, effective November 18, 2025, due to personal commitments. Mr. Tu Lei, with extensive experience in corporate finance and management, has been appointed to fill this role. Additionally, Mr. Tu will serve as the company’s new Chief Executive Officer, bringing a wealth of experience from his previous roles at major financial institutions. This strategic appointment is expected to enhance the company’s leadership and potentially strengthen its market position.
More about BrainAurora Medical Technology Limited
BrainAurora Medical Technology Limited operates in the medical technology industry, focusing on innovative healthcare solutions. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 35,870,444
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$8.17B
See more data about 6681 stock on TipRanks’ Stock Analysis page.